IntegReview IRB has five (5) Boards that meet daily and can meet ad-hoc for unscheduled meetings (as needed). We review many therapeutic area and fields of research, including but limited to:
- Medical Device
- Consumer Preference
- Observational / Registry
- Research conducted in academic and hospital settings
- Expedited review procedure for research that qualifies, as identified in the Federal Register
- Humanitarian Use Device (HUD)
- Dietary Supplement
- Exempt projects
Our clients include dedicated Sponsors, CROs, research clinics, institutions, hospitals, independent researchers, educators and evaluators.
We can provide oversight in the United States and certain regions in Latin America. The following Latin American regions require local IRB/IEC review; therefore, IntegReview is unable to review research in Argentina, Brazil, Chile, Columbia, Mexico, Paraguay, Peru and Uruguay.
IntegReview can collaborate on the review of Canadian research sites / investigators.
IntegReview IRB also provides the following services:
Board Member Consultancy (Pre-Review)
Informed Consent Development
PI Database - Site identification services, as requested
Document rush requests